biostudies-literatureUnknown6(1)Llaneras JGilead Sciences<h4>Background & aims</h4>Many people with HCV and HBV infection are unaware of their condition, particularly at-risk and vulnerable populations who face barriers for screening and linkage to care. Emergency departments are often their only point of contact with the health system.<h4>Methods</h4>This is a prospective study investigating HBsAg and HCV antibody testing, with reflex testing for HDV antibodies and HCV RNA, in adults attending an emergency department and requiring a blood test. Positive cases were linked to care. A cost-effectiveness analysis was performed.<h4>Results</h4>From February 2020 to February 2022, a total of 17,560 individuals were screened. HBsAg was detected in 91 (0.5%), HCV RNA in 128 (0.7%), and HDV antibodies in two (0.01%) individuals. Nearly 40% of positive cJHEP reports : innovation in hepatology100932https://www.ebi.ac.uk/biostudies/studies/S-EPMC10698271biostudies-literatureIntegrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.PMC10698271Falco-Roget ARiveiro-Barciela MRuiz-Cobo JCCampins MRando-Segura AMonforte AMeza BLlaneras JRuiz LPumarola TButi MRodriguez-Frias FBarreira-Diaz ABlanco-Grau ABanares JColom JDominguez-Hernandez REsteban RCasado MAfalseIntegrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.<h4>Background & aims</h4>Many people with HCV and HBV infection are unaware of their condition, particularly at-risk and vulnerable populations who face barriers for screening and linkage to care. Emergency departments are often their only point of contact with the health system.<h4>Methods</h4>This is a prospective study investigating HBsAg and HCV antibody testing, with reflex testing for HDV antibodies and HCV RNA, in adults attending an emergency department and requiring a blood test. Positive cases were linked to care. A cost-effectiveness analysis was performed.<h4>Results</h4>From February 2020 to February 2022, a total of 17,560 individuals were screened. HBsAg was detected in 91 (0.5%), HCV RNA in 128 (0.7%), and HDV antibodies in two (0.01%) individuals. Nearly 40% of positive c2024-01-01T00:00:00Z2024 Jan2026-07-14T22:54:55.088Z2025-04-06T05:22:16.571ZS-EPMC106982713807450610.1016/j.jhepr.2023.100932